|
|
<section data-role="paragraph" data-color="rgb(182, 228, 253)" data-custom="rgb(182, 228, 253)"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section><p><p><img src="image/20201014/86b79d371e9862b01189f0252a03b2cd_1.png" /></p></p></section><section><section><span><strong></strong></span></section><p><span>医疗器械媒体报道先锋</span></p><p><span>分享专业医疗器械知识</span></p></section><section><section><section><span>关注</span></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><p><br /></p><section><span>根据美国Medical Design & Outsourcing网站评选的全球前100家医疗器械公司和CMS Open Payment网站的公开数据分析，2018年全球前20家最大的医疗器械上市公司向医生和教学医院提供了1.599亿美元的科研支持。平均算起来，2018年每家公司将其年收入的0.1%、研发支出的1.2%，“砸”向医生和教学医院。这些费用主要用于对设备的研究，如评估支架、缝合线、医学影像设备等的安全性和有效性。</span></section><section><span><br /></span></section><section><span>其中，美敦力“砸”了6400万美元，位居榜首。（这些款项是其研发支出的2.7％和2019年年收入的0.2％。）雅培“砸”了美敦力的1/3左右，位居第二。波士顿科学“砸”了1940万美元，排名第三。大佬们“砸”起钱来一点都不吝啬呀！快来看看全球前10的医械企业“砸”向医生和教学医院的钱都干了些啥！</span></section><section> <p><img src="image/20201014/0cbe602616bd13131ae63d8d91a0602e_2.png" /></p></section><section><br /></section><section><span><strong><span>一、美敦力：有哪些钱砸向了医生及教学医院？</span></strong></span></section><section><br /></section><section><p><img src="image/20201014/31034be015ab9060d3accdd3bfb8bdc2_3.png" /></p></section><section><br /></section><section><span>用于医生和教学医院的研究经费：6400万美元</span></section><section><span>百强企业排名：1</span></section><section><span>研发支出的2.7％（23.3亿美元）</span></section><section><span>占年收入的0.2％（305.57亿美元）</span></section><section><br /></section><section><span>1、Medtronic</span></section><section><span><br /></span></section><section><span>Medtronic美国的医用经费总额为115,686美元，主要用于药物输注和神经刺激设备；向美国的教学医院支付的研究经费共计306,519美元，用于Micra起搏器研究。</span></section><section><span><br /></span></section><section><span>105,204美元涉及与SynchroMed输液系统和Ascenda导管有关研究；</span></section><section><span><br /></span></section><section><span>10,481美元用于涉及Pisces（第一种用于治疗四肢长期疼痛的脊椎刺激仪），Vectris（ 脊椎神经刺激电极），PrimeAdvanced（植入式神经刺激系统），Intellis（植入式神经刺激器）和特定设备的脊髓神经刺激研究。</span></section><section><span><br /></span></section><section><span>2、Medtronic Minimed</span></section><section><span><br /></span></section><section><span>子公司Medtronic Minimed的医用经费共计108,312美元，主要用于Minimed 670G胰岛素泵系统和Enlite传感器的研究；向美国的教学医院支付的研究经费共计13,163美元。</span></section><section><span><br /></span></section><section><span>47,972美元用于Minimed 670G胰岛素泵系统相关研究；</span></section><section><span><br /></span></section><section><span>30,340美元用于与儿科的相关研究 ；</span></section><section><span><br /></span></section><section><span>15,000美元用于Enlite连续血糖监测相关研究。</span></section><section><span> </span><p><img src="image/20201014/d07938a901965d07b1a7d6a76522e31c_4.png" /></p><span>美敦力MiniMed 670G胰岛素泵</span></section><section><br /></section><section><span>3、Medtronic USA</span></section><section><span><br /></span></section><section><span>子公司Medtronic USA的医用经费总计215,925美元，主要用于研究人员进行研究；向美国的教学医院支付研究经费共计134,455美元，用于激光消融和刺激设备。</span></section><section><span><br /></span></section><section><span>40,000美元用于研究Visualase MRI引导的激光消融；</span></section><section><span><br /></span></section><section><span>39,822美元用于CD Horizon脊柱系统研究；</span></section><section><span><br /></span></section><section><span>24,741美元用于Visualase项目相关研究；</span></section><section><span><br /></span></section><section><span>17045美元用于Interstim神经刺激相关研究；</span></section><section><span><br /></span></section><section><span>12,847美元用于恢复脊髓神经刺激相关研究。</span></section><section><span><br /></span></section><section><span>4、Medtronic Vascular</span></section><section><span><br /></span></section><section><span>子公司Medtronic Vascular的医用经费共计66,461美元，主要用于植入式心脏复律除颤器和套管研究；向美国的教学医院支付研究经费共计669,596美元，主要用于经导管瓣膜系统，抗菌网和支架研究。</span></section><section><span><br /></span></section><section><span>24,140美元用于涉及Bio-Medicus插管相关研究；</span></section><section><span><br /></span></section><section><span>13,743美元用于涉及Viva心脏再同步治疗除颤器（CRT-Ds）研究；</span></section><section><span><br /></span></section><section><span>10,557美元用于Evera ICD（用于快速性心律失常管理的植入式心脏复律除颤器）相关研究 ；</span></section><section><span><br /></span></section><section><span>18030美元用于Viva CRT-D（用于心力衰竭管理的心脏再同步治疗除颤器）的相关研究；</span></section><section><span><br /></span></section><section><span>157,475美元用于CoreValve（非侵入性主动脉瓣替换系统）和Evolut TAVR（经导管主动脉心脏瓣膜）项目研究；</span></section><section><span><br /></span></section><section><span>128,800美元用于Tyrx抗菌网项目研究；</span></section><section><span><br /></span></section><section><span>117,661美元用于Resolute支架项目研究。</span></section><section><br /></section><section><strong><span>二、雅培：有哪些钱砸向了医生及医学院？</span></strong></section><section><br /></section><section><p><img src="image/20201014/af0ef75ac3aa76caf4530e50056d0319_5.png" /></p><span></span></section><section><br /></section><section><span>用于医生和教学医院的研究经费：2320万美元</span></section><section><span>百强企业排名：11</span></section><section><span>占年度收入的0.2％（114亿美元） </span></section><section><span><br /></span></section><section><span>雅培在美国的医用经费共计655,329美元，主要用于诊断和心脏设备研究；向美国的教学医院支付研究经费共计669,596美元，主要用于经导管瓣膜系统，抗菌网和支架研究。</span></section><section><span><br /></span></section><section><span>156,827美元用于与Alere Triage免疫测定相关的研究;</span></section><section><span><br /></span></section><section><span>134,729美元用于Alere检测与建筑师诊断系统配合使用以帮助诊断心力衰竭；</span></section><section><span><br /></span></section><section><span>185,086美元用于比较光学相干断层扫描（OCT）引导的冠状动脉支架植入术与血管造影术；</span></section><section><span><br /></span></section><section><span>134,993美元用于刚果病毒株的多样性；</span></section><section><span><br /></span></section><section><span>111,750美元用于MitraClip经导管二尖瓣修复系统项目研究。</span></section><section><span><br /></span></section><section><span><strong><span>三、波士顿科学：有哪些钱砸向了医生及教学医院？</span></strong></span></section><section><br /></section><section><p><img src="image/20201014/e22de6c1a6b85abb49066b785ed8972b_6.png" /></p><span></span></section><section><br /></section><section><span>用于医生和教学医院的研究经费：1,940万美元</span></section><section><span>百强企业排名：14</span></section><section><span>占研发支出的1.7％（11.13亿美元）</span></section><section><span>占年收入的0.2％（98.23亿美元） </span></section><section><span><br /></span></section><section><span>波士顿科学在美国的医用经费共计23,831美元，主要用于盆腔器官脱垂和疼痛管理设备；向美国的教学医院支付研究经费共计1,384,502美元，主要用于结构性心脏装置、支架和诊断设备。</span></section><section><span><br /></span></section><section><span>11,166美元用于Uphold Lite阴道支撑系统项目研究（FDA 于去年下令停止销售该系统）；</span></section><section><span><br /></span></section><section><span>10,265美元用于与Spectra Wavewriter疼痛管理相关研究；</span></section><section><span><br /></span></section><section><span>2,400美元用于Xenform盆腔器官脱垂项目研究（去年也从市场中撤出了这项研究）。</span></section><section><span><br /></span></section><section><span>819,625美元用于Watchman结构性心脏装置研究；</span></section><section><span><br /></span></section><section><span>221,425美元用于Synergy心脏支架相关研究；</span></section><section><span><br /></span></section><section><span>100,000美元用于Rhythmia心脏诊断装置相关研究。</span></section><section><span><br /></span></section><section><span><strong><span>四、GE医疗：有哪些钱砸向了医生及教学医院？</span></strong></span></section><section><br /></section><section><p><img src="image/20201014/9bd23b26689c8a851b0318fba70cef94_7.png" /></p><span></span></section><section><br /></section><section><span>用于医生和教学医院的研究经费：1090万美元</span></section><section><span>百强企业排名：4</span></section><section><span>占年度收入的0.1％（197.84亿美元）</span></section><section><span><br /></span></section><section><span>GE医疗在美国的医用经费共计为3,357美元，主要用于研究Visipaque造影剂对对肾功能的影响；向美国医学院支付的研究经费总计966,783美元，主要用于与医学影像设备有关的研究。</span></section><section><span><br /></span></section><section><span>554,133美元用于支持机器学习和信息学技术的开发和部署；</span></section><section><span><br /></span></section><section><span>162,100美元用于探讨Invenia ABUS（自动全乳超声）的实施情况以及评估ABUS作为辅助性筛查手段在检测乳腺癌中的功效；</span></section><section><span><br /></span></section><section><span>149,300美元用于Invenia ABUS超声设备研究；</span></section><section><span><br /></span></section><section><span>101,250美元用于一项核心成像研究项目相关。</span></section><section><span><br /></span></section><section><span><strong><span>五、碧迪：有哪些钱砸向了医生及教学医院？</span></strong></span></section><section><br /></section><section><p><img src="image/20201014/bd095e7295c8d91fe24949a349435a56_8.png" /></p><span></span></section><section><br /></section><section><span>用于医生和教学医院的研究经费：1,050万美元</span></section><section><span>百强企业排名：16</span></section><section><span>占年度收入0.1％（86.16亿美元）</span></section><section><span><br /></span></section><section><span>碧迪在美国的医用经费共计为231,580美元，主要用于研究针头研究和分子检测。向美国的教学医院支付的研究经费总计604,487美元，主要用于分子诊断系统的研究。</span></section><section><span><br /></span></section><section><span>139,383美元用于BD Nano纳米笔针项目研究；</span></section><section><span><br /></span></section><section><span>63,925美元用于BD Viper分子测试系统项目研究；</span></section><section><span><br /></span></section><section><span>28,272美元用于医疗系统相关研究。</span></section><section><br /></section><section><p><img src="image/20201014/10324cc3a1fb1e4e383f336f64496a8a_9.jpg" /></p><span>BD MAX分子诊断系统</span></section><section><span><br /></span></section><section><span>178,457美元用于涉及BD Max分子诊断系统的研究，该系统可进行核酸提取和实时PCR；</span></section><section><span><br /></span></section><section><span>136,305美元用于BD Viper分子测试系统相关的研究；</span></section><section><span><br /></span></section><section><span>120,528美元用于涉及BD Kiestra实验室自动化解决方案的研究；</span></section><section><span><br /></span></section><section><span>86,534美元用于诊断系统研究；</span></section><section><span><br /></span></section><section><span>82,663美元用于涉及与BD Max分子诊断系统相关的研究。</span></section><section><span><br /></span></section><section><span><strong><span>六、捷美：有哪些钱砸向了医生及教学医院？</span></strong></span></section><section><span><br /></span></section><section><p><img src="image/20201014/f5feb2a1495f534d171de624e1c7ece4_10.png" /></p><span></span></section><section><br /></section><section><span>用于医生和教学医院的研究经费：910万美元</span></section><section><span>百强企业排名：18</span></section><section><span>研发支出的2.3％（3.917亿美元）</span></section><section><span>年度收入的0.1％（793.290亿美元）</span></section><section><span><br /></span></section><section><span>捷美在美国的医用经费共计为131,015美元，主要用于运动医学研究和髋部器械；向美国的教学医院支付的研究经费总计390,374美元，主要用于骨科器械。</span></section><section><span><br /></span></section><section><span>76,990美元用于nStride膝关节注射盐碱对照研究；</span></section><section><span><br /></span></section><section><span>31,150美元用于评估上颌后牙和后下颌骨的小梁金属牙植入物项目；</span></section><section><span><br /></span></section><section><span>22,875美元用于Taperloc髋关节项目相关研究；</span></section><section><span><br /></span></section><section><span>16,838美元用于Vanguard E1胫骨轴承项目研究；</span></section><section><span><br /></span></section><section><span>81,472美元用于全髋关节置换术中模块化中Dual Mobility髋臼组件与传统轴承组件之间的关系研究；</span></section><section><span><br /></span></section><section><span>74,194美元用于运动学相关研究；</span></section><section><span><br /></span></section><section><span>67,000美元用于使用AccuPort和AccuFill设备进行软骨下冲击研究；</span></section><section><span><br /></span></section><section><span>50,870美元用于使用HealthLoop管理全髋关节置换术和全膝关节置换术的护理过程。</span></section><section><span><br /></span></section><section><span><strong><span>七、史赛克：有哪些钱砸向了医生及教学医院？</span></strong></span></section><section><br /></section><section><p><img src="image/20201014/8cb195fa5ef812218ebcedf4637ed74f_11.png" /></p><span></span></section><section><br /></section><section><span>用于医生和教学医院的研究经费：820万美元</span></section><section><span>百强企业排名：9</span></section><section><span>研发支出的1％（8.62亿美元）</span></section><section><span>占年收入的0.1％（136亿美元） </span></section><section><span><br /></span></section><section><span>史赛克在美国的医用经费共计261,107美元，主要用于购买Sage产品和骨科设备；向美国的教学医院支付的研究经费共计949,917美元，主要用于Mako手术机器人系统及Atlas颅内支架。</span></section><section><span><br /></span></section><section><span>130,367美元用于与Sage加热器相关的研究；</span></section><section><span><br /></span></section><section><span>57,834美元用于Lin Protect OC项目研究；</span></section><section><span><br /></span></section><section><span>36,453美元用于Tritanium髋关节和Triathlon膝盖相关设备研究；</span></section><section><span><br /></span></section><section><span>393,104美元用于治疗神经血管动脉瘤和外周栓塞的Target可拆卸线圈项目；</span></section><section><span><br /></span></section><section><span>192,375美元用于使用Mako系统进行的机器人辅助全膝关节置换术的上市后研究；</span></section><section><span><br /></span></section><section><span>131,397美元用于Atlas颅内支架相关研究；</span></section><section><span><br /></span></section><section><span>100,000美元用于Mako手术机器人系统的研究。</span></section><section><span><br /></span></section><section><span><strong><span>八、飞利浦医疗：有哪些钱砸向了医生及教学医院？</span></strong></span></section><section><span> </span><p><img src="image/20201014/1c28c2ab0b84789d84da3e58a84b22e0_12.png" /></p><br /></section><section><span></span></section><section><br /></section><section><span>用于医生和教学医院的研究经费：680万美元</span></section><section><span>百强企业排名：3</span></section><section><span>研发支出的0.3％（20.79亿美元）</span></section><section><span>年收入的0.03％（214.14亿美元）</span></section><section><span><br /></span></section><section><span>飞利浦医疗在美国的医用经费共计103,174美元，向美国的教学医院支付的研究经费1,978,149美元，主要用于心脏病和血管疾病设备。</span></section><section><span><br /></span></section><section><span>28,800美元用于Achieva 3.0T R5 MRI系统；</span></section><section><span><br /></span></section><section><span>25,600美元用于Ingenia 1.5T MRI系统；</span></section><section><span><br /></span></section><section><span>18,000美元用于Ingenia 3.0T MRI系统和MicroDose SI乳腺摄影系统的临床前研究；</span></section><section><span><br /></span></section><section><span>16,000美元用于Achieva 3.0T R5 MRI临床前研究；</span></section><section><span><br /></span></section><section><span>1,375,000美元用于心脏病，血管相关设备的研究；</span></section><section><span><br /></span></section><section><span>282,584美元用于中风疾病研究;</span></section><section><span><br /></span></section><section><strong><span>九、西门子医疗：有哪些钱砸向了医生及教学医院？</span></strong></section><section><br /></section><section><p><img src="image/20201014/bffd479712df596e2ae262db04317f07_13.png" /></p><span></span></section><section><br /></section><section><span>用于教学医院的研究经费：620万美元</span></section><section><span>百强企业排名：6</span></section><section><span>占研发支出的0.4％（15.14亿美元）</span></section><section><span>占年收入的0.03％（158.64亿美元） </span></section><section><span><br /></span></section><section><span>西门子医疗向美国的教学医院支付的研究经费共计919,071美元，用于超声波和X射线设备。</span></section><section><span><br /></span></section><section><span>547,472美元用于研究混合型机器人血管造影和MRI系统的临床前研究。</span></section><section><span><br /></span></section><section><span>131,802美元与Artis Zeego固定式X射线/血管造影荧光透视检查设备；</span></section><section><span><br /></span></section><section><span>85,000美元用于心脏病研究；</span></section><section><span><br /></span></section><section><span>78,822美元用于固定式X射线/血管造影透视检查的软件及配件；</span></section><section><span><br /></span></section><section><span>75,975美元用于SC2000超声系统项目研究。</span></section><section><span><br /></span></section><section><strong><span>十、强生：有哪些钱砸向了医生及教学医院？</span></strong></section><section><span><br /></span></section><section><span> </span><p><img src="image/20201014/e1670990860247bbcc8cd66fe9e308fe_14.png" /></p></section><section><br /></section><section><span>用于医生和教学医院的研究经费：160万美元</span></section><section><span>百强企业排名：2</span></section><section><span>研发支出的0.1％（17.64亿美元）</span></section><section><span>年度收入的0.005％（270亿美元）</span></section><section><span><br /></span></section><section><span>1.DePuy Synthes</span></section><section><span><br /></span></section><section><span>子公司DePuy Synthes向美国的教学医院支付的研究经费共计183,989美元，主要用于骨科器械研究。</span></section><section><span><br /></span></section><section><span>77,710美元用于Ortho-Knee系统相关研究；</span></section><section><span><br /></span></section><section><span>34,000美元用于研究使用承重和软组织相互作用评估来表征高级全膝关节置换的设计；</span></section><section><span><br /></span></section><section><span>24,093美元用于评估TFN Advanced植入物的材料特性研究。</span></section><section><span><br /></span></section><section><span>2.Biosense Webster</span></section><section><span><br /></span></section><section><span>子公司Biosense Webster向美国的教学医院支付的研究经费共计152,725美元，主要用于心脏设备和研究。</span></section><section><span><br /></span></section><section><span>43,211美元用于临床前相关研究；</span></section><section><span><br /></span></section><section><span>31,563美元用于涉及心脏病设备Pentaray和治疗导管Thermocool相关研究；</span></section><section><span><br /></span></section><section><span>23,194美元用于心脏病学的临床前研究 。</span></section><section><span><br /></span></section><h3><section><span><strong><span>结语</span></strong></span></section><section><span><br /></span></section></h3><section><span>无论是顶级医疗器械企业“砸”钱给医生和教学医院的大方，还是这些经费流向监督管理的有力，都值得国内医械企业借鉴。如果国内医械企业也能做到透明、公开、规范，想必市场环境会更好，公众也会给予更多的信赖。</span></section><section><span><br /></span></section><p><span>来源：高特佳投资</span></p><p><br /></p><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="paragraph"><section><section><section data-brushtype="text"><strong>相关阅读</strong></section></section></section><section><section><br /></section></section><section data-width="100%"><section><section><section><section data-width="100%"><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><section><p><img src="image/20201014/2aac877ff9233ba5a66e7a5ff3a4febf_15.gif" /></p></section><section data-brushtype="text">戳一下，更有料！</section></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972852&idx=1&sn=9607a43ead67d233ae695575598aac5c&chksm=843f45a3b348ccb55159454d372bad63f1e3197a647461d3fc8e8739c991eb4764c4f27f6f34&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">新冠病毒进入人体的21天</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972844&idx=2&sn=cbcb6cd5a90d3484820434b676e299a7&chksm=843f45bbb348ccad45d0a9074578b5197adf33494071038768acfd955957f872275a192b4e13&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">一图读懂丨新冠病毒核酸、抗体、抗原检测区别！</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972843&idx=1&sn=155209626bcfc5f6b9de2ce3aff3f3a0&chksm=843f45bcb348ccaaeee3857e512c845b912d5013361482794e3ef2fafcbe169f11bd3f17351a&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">定了！国务院：推行一票制！</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972843&idx=2&sn=1091ea8c52cb5a57a2f3daa1dc090213&chksm=843f45bcb348ccaa3ff57c2ca2277fde0887dd45abee3282f3b0b4e9361a4cafe256f97504d5&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">GE发布新冠肺炎CT影像智能分析平台——“智赢新冠LK2.0”</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972843&idx=4&sn=f6e0167bc1dba79ce4b1bcfcf7a8e66e&chksm=843f45bcb348ccaadc2997e3703120c689ef8f170ab25756e8ee600728af3eeceac74fbb4234&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">大量新冠肺炎患者出院后复阳！为什么复阳，看看专家怎么说。</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972821&idx=2&sn=d7c91c9e988e7b66278ef8ab5f49186f&chksm=843f4582b348cc94b888be5fdf2ee8232679c6ac7aee57e5a5040f1da9034623c3b7cdeb3fff&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">全球首款便携式MRI，拿证了！</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972755&idx=1&sn=78e1a604cfbc2adba3fb147fb01cba19&chksm=843f4444b348cd5286c8e70f76785bc93cc4030164fbfd0f54df7464012efc2f2b3ba117920f&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">口罩成全球紧俏物资！</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972755&idx=2&sn=ed186cf75bb9cbee4a65a8e99a5cdfec&chksm=843f4444b348cd521710a028e73654f516b425ec3ddaed9f95a664c8a0d43c3286b697fb7461&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">世卫组织：将新冠肺炎疫情全球风险级别上调至“非常高”</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972744&idx=1&sn=d60e52eb34ec121ebfe1c3b9379d15ef&chksm=843f445fb348cd49e0ef20bc1209d886649abb387e29543f4ce088773bdf31ab520d82c7d3f1&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">新冠病毒的自我修养：如何统治全人类</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972744&idx=2&sn=9bb22b5cd704f1556b7e705d4eac8d5d&chksm=843f445fb348cd498ded41200f2b763c73c6bb49e3e1b342e3c9e562be5b64518bfcb9b5471d&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">新冠肺炎患者的最后时刻，是什么样的？</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972717&idx=2&sn=8922bbe888ec76328d9a92809a5703e3&chksm=843f443ab348cd2c06500b07fb3d6ba18bcf89977feeb75b8ca418801adcd1ec9edb0a0b0a86&scene=21#wechat_redirect" data-itemshowtype="11" tab="innerlink" data-linktype="2" hasload="1">21世纪10年代十个伟大的医学科技进步（一）</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972717&idx=3&sn=338056b2cce4fc2fcc36218c004dff69&chksm=843f443ab348cd2cb674ba90187327d8eb175068b7c0a3044b960c543d767afa6efbe27f0ca0&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">WHO专家组考察武汉后说...</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972701&idx=1&sn=6435a405605af3923b3b0f532b9dfa29&chksm=843f440ab348cd1cf8d10baffda06c6861309fe0ea8160e266b7a4004207e0250450b5abbcf5&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">负压急救车！造起来究竟有多难？</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972701&idx=2&sn=5a6a3393e0f5fa792995f5475d4a628a&chksm=843f440ab348cd1c84b4570466e07184aea35a4dc39d001e1135f8b88c4d46df8fda704604b5&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">又见跨界，格力2000万入局医疗器械！</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972683&idx=1&sn=5ad665c1785fb550563b1d61d29c9b9c&chksm=843f441cb348cd0ae4dd0931893a70369a75614e328b9e47a6b800cc4ffa4f7631d66765ef5c&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">盘点方舱医院的硬核“武器”——“方舱”CT!</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972683&idx=3&sn=18bbefe742b1545a1a99109a37d40072&chksm=843f441cb348cd0ad73034ba501d97ebf7a1c3d44434127dfa52630baea91b59c52ef01586e1&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">危机！美国CDC称新冠肺炎将在美国大爆发</a><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652972635&idx=1&sn=4c5be600efd8de6f2ed0ba44bf0f6ef1&chksm=843f44ccb348cddac112bf2049f2c1d6014330e4fc95a64d0eb4037bfb857a9ad6fef1687957&scene=21#wechat_redirect" data-itemshowtype="11" tab="innerlink" data-linktype="2" hasload="1">“测温枪”到底是怎样测出你的温度的？</a></section></section></section></section></section></section></section></section></section><p><br /></p><p><p><img src="image/20201014/aad9f56b0707b5374bbac6273a663447_16.jpg" /></p></p><p><br /></p>
|
|
发表于 2020-10-14 12:48:01